Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
Nomura Stock Upgraded to Buy by BofA as Stronger ROE and Earnings Growth Boost Outlook 
Trump Lawyers Face Scrutiny After Missing Deadline in $10 Billion BBC Defamation Lawsuit 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
U.S. Supreme Court to Review Trump Administration Appeal on Immigrant Detention Without Bond Hearings 
Apple Supplier Stocks Slide as Samsung, SK Hynix Lead Selloff After Apple Price Hikes 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Trump Administration Urges Judge to Allow UFC Event on White House Lawn 
Colombia Opens New Investigation Into Former President Álvaro Uribe Over Paramilitary Allegations 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike 
South Korea Ex-President Yoon Suk Yeol Sentenced to 30 Years Over Martial Law Plot 
DOJ Sues Virginia Over Law Enforcement Mask Ban 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
The Missouri Supreme Court rejected Johnson & Johnson's appeal of a ruling by the Missouri Court of Appeals awarding $2.12 billion damages to women who blamed the company's asbestos-tainted products for their ovarian cancer.
The New Brunswick, New Jersey-based firm called the verdict a product of fundamentally flawed trial, grounded in a faulty presentation of the facts and vowed to elevate the case to the US Supreme Court.
Johnson & Johnson insists that there were decades of independent scientific evaluations that found their product safe, asbestos-free, and not cancer-causing.
In July 2018, a jury ruled that Johnson & Johnson was liable $4.69 billion to the complainants.
The Missouri Court of Appeals upheld the jury verdict on June 23 but reduced the payout to $2.12 billion after dismissing claims by 22 plaintiffs.
It said that it may be inferred from evidence that the company disregarded consumer safety for profit.
Kevin Parker, a lawyer for the plaintiffs, said that Johnson & Johnson should accept the verdict of the jury and the appellate court and compensate the victims.
Johnson & Johnson said it would set aside a $2.1 billion reserve for the verdict.
The company, which said that it would stop selling its Baby Powder talc in the US and Canada, revealed that it faces over 21,800 lawsuits claiming that its talc products contain asbestos, a known carcinogen.
Johnson & Johnson's baby powder was intensely scrutinized for safety after a 2018 Reuters investigative report said that it knew for decades that about the asbestos contamination of its talc.
Evidence showed that from at least 1971 to the early 2000s,
Johnson & Johnson's raw talc and finished powders have tested positive for small amounts of asbestos.
